Results: 1-24 |
Results: 24

Authors: Rhee, HW Zhau, HE Pathak, S Multani, AS Pennanen, S Visakorpi, T Chung, LWK
Citation: Hw. Rhee et al., Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel, IN VITRO-AN, 37(3), 2001, pp. 127-140

Authors: Edlund, M Miyamoto, T Sikes, RA Ogle, R Laurie, GW Farach-Carson, MC Otey, CA Zhau, HYE Chung, LWK
Citation: M. Edlund et al., Integrin expression and usage by prostate cancer cell lines on laminin substrata, CELL GROWTH, 12(2), 2001, pp. 99-107

Authors: Gardner, TA Ko, SC Yang, L Cadwell, JJS Chung, LWK Kao, C
Citation: Ta. Gardner et al., Serum-free recombinant production of adenovirus using a hollow fiber capillary system, BIOTECHNIQU, 30(2), 2001, pp. 422

Authors: Pisters, LL Wang, XH Chung, LWK Hsieh, JT
Citation: Ll. Pisters et al., Differential expression of c-erb B2/neu, epidermal growth factor receptor,cytokeratin 8, and the prostatic steroid-binding protein gene in rat ventral prostate during postnatal development, PROSTATE, 47(3), 2001, pp. 164-171

Authors: Cinar, B Koeneman, KS Edlund, M Prins, GS Zhau, HE Chung, LWK
Citation: B. Cinar et al., Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line, CANCER RES, 61(19), 2001, pp. 7310-7317

Authors: Matsubara, S Wada, Y Gardner, TA Egawa, M Park, MS Hsieh, CL Zhau, HE Kao, C Kamidono, S Gillenwater, JY Chung, LWK
Citation: S. Matsubara et al., A conditional replication-competent adenoviral vector, Ad-OC-E1a, to cotarget prostate cancer and bone stroma in an experimental model of androgen-independent prostate cancer bone metastasis, CANCER RES, 61(16), 2001, pp. 6012-6019

Authors: Chung, LWK Zhau, HE
Citation: Lwk. Chung et He. Zhau, Stromal-epithelial interaction - From bench to bedside, CONT CANC R, 2001, pp. 341-362

Authors: Shirakawa, T Gotoh, A Wada, Y Kamidono, S Ko, SC Kao, CH Gardner, TA Chung, LWK
Citation: T. Shirakawa et al., Tissue-specific promoters in gene therapy for the treatment of prostate cancer, MOL UROL, 4(2), 2000, pp. 73-82

Authors: Komata, T Kondo, Y Koga, S Ko, SC Chung, LWK Kondo, S
Citation: T. Komata et al., Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53, GENE THER, 7(24), 2000, pp. 2071-2079

Authors: Ye, QN Chung, LWK Cinar, B Li, SW Zhau, HE
Citation: Qn. Ye et al., Identification and characterization of estrogen receptor variants in prostate cancer cell lines, J STEROID B, 75(1), 2000, pp. 21-31

Authors: Koeneman, KS Kao, CH Ko, SC Yang, L Wada, Y Kallmes, DF Gillenwater, JY Zhau, HE Chung, LWK Gardner, TA
Citation: Ks. Koeneman et al., Osteocalcin-directed gene therapy for prostate-cancer bone metastasis, WORLD J URO, 18(2), 2000, pp. 102-110

Authors: Sokoloff, MH Nardin, A Solga, MD Lindorfer, MA Sutherland, WM Bankovich, AJ Zhau, HE Chung, LWK Taylor, RP
Citation: Mh. Sokoloff et al., Targeting of cancer cells with monoclonal antibodies specific for C3b(i), CANCER IMMU, 49(10), 2000, pp. 551-562

Authors: Thalmann, GN Sikes, RA Wu, TT Degeorges, A Chang, SM Ozen, M Pathak, S Chung, LWK
Citation: Gn. Thalmann et al., LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis, PROSTATE, 44(2), 2000, pp. 91-103

Authors: Ye, QN Chung, LWK Li, SW Zhau, HYE
Citation: Qn. Ye et al., Identification of a novel FAS/ER-alpha fusion transcript expressed in human cancer cells, BBA-GENE ST, 1493(3), 2000, pp. 373-377

Authors: Hsieh, JT Dinney, CPN Chung, LWK
Citation: Jt. Hsieh et al., The potential role of gene therapy in the treatment of bladder cancer, UROL CLIN N, 27(1), 2000, pp. 103

Authors: Yeung, F Li, XY Ellett, J Trapman, J Kao, CH Chung, LWK
Citation: F. Yeung et al., Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells, J BIOL CHEM, 275(52), 2000, pp. 40846-40855

Authors: Thalmann, GN Sikes, RA Devoll, RE Kiefer, JA Markwalder, R Klima, I Farach-Carson, CM Studer, UE Chung, LWK
Citation: Gn. Thalmann et al., Osteopontin: Possible role in prostate cancer progression, CLIN CANC R, 5(8), 1999, pp. 2271-2277

Authors: Hyytinen, ER Frierson, HF Boyd, JC Chung, LWK Dong, JT
Citation: Er. Hyytinen et al., Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer, GENE CHROM, 25(2), 1999, pp. 108-114

Authors: Hyytinen, ER Frierson, HF Sipe, TW Li, CL Degeorges, A Sikes, RA Chung, LWK Dong, JT
Citation: Er. Hyytinen et al., Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer, PROSTATE, 41(3), 1999, pp. 190-195

Authors: Koeneman, KS Yeung, F Chung, LWK
Citation: Ks. Koeneman et al., Osteomimetic properties of prostate cancer cells: A hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment, PROSTATE, 39(4), 1999, pp. 246-261

Authors: Nelson, JB Nguyen, SH Wu-Wong, JR Opgenorth, TJ Dixon, DB Chung, LWK Inoue, N
Citation: Jb. Nelson et al., New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade, UROLOGY, 53(5), 1999, pp. 1063-1069

Authors: Shirakawa, T Gardner, TA Ko, SC Bander, N Woo, S Gotoh, A Kamidono, S Chung, LWK Kao, C
Citation: T. Shirakawa et al., Cytotoxicity of adenoviral-mediated cytosine deaminase plus 5-fluorocytosine gene therapy is superior to thymidine kinase plus acyclovir in a human renal cell carcinoma model, J UROL, 162(3), 1999, pp. 949-954

Authors: Degeorges, A Wang, F Frierson, HF Seth, A Chung, LWK Sikes, RA
Citation: A. Degeorges et al., Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1, CANCER RES, 59(12), 1999, pp. 2787-2790

Authors: Sokoloff, MH Chung, LWK
Citation: Mh. Sokoloff et Lwk. Chung, Targeting angiogenic pathways involving tumor-stromal interaction to treatadvanced human prostate cancer, CANC METAST, 17(4), 1998, pp. 307-315
Risultati: 1-24 |